Scipher Hopes IBD Alliance With Galapagos Is The First Of Many

 
• By Joseph Haas

Focused primarily on developing diagnostic tests to determine whether patients will respond to a drug, Scipher is also using the data from its artificial intelligence process to drive R&D partnerships with drug developers.

Abstract matrix digital numbers artifical intelligence ai theme with human face
Scipher uses AI to sort patient data to predict response or non-response to a drug

More from Deals

More from Business